Loading
Akash Bakshi

Akash Bakshi

CEO, YourChoice Therapeutics
United States
In 2018, Akash Bakshi co-founded YourChoice Therapeutics, a company that spun out of University of California, Berkeley. Since then, he has served as CEO. The company was accepted into the Winter 2019 batch of Y Combinator, the most competitive seed accelerator in the United States. To date, Akash has secured >20M in investment, the largest amount of funding raised for a private contraceptive biotech. In March 2020, Akash co-founded ANA Therapeutics to develop - a small molecule into an oral COVID-19 therapeutic. ANA was a subsidiary of YourChoice Therapeutics. He raised >6M dollars for the subsidiary and assembled a team of infectious disease, biostatistics, CMC, clinical operations, and regulatory experts, as well as members of the Data Monitoring Committee (DMC). ANA Therapeutics received the “Study-May-Proceed” Letter from the FDA 3.5 months after its incorporation and a Phase 2/3 trial with hospitalized COVID-19 patients is ongoing. ANA Therapeutics was acquired by NeuroBo Pharmaceuticals in December 2020 (In less than 9 months from incorporation). At NeuroBo Pharmaceuticals Akash served as a member of their Nasdaq compliant board, served as Chief Operating Officer, and raised $20+ million dollars on the public market to advance internal objectives.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS